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Summary 
The T  cell receptor [3 (TCR[3) chain controls the developmental transition from CD4-CD8- 
to CD4+8+thymocytes. We show that the extracellular constant region and the transmembrane 
region, but not the variable domain or cytoplasmic tail of the TCPq3 chain are required for this 
differentiation step. TCI<[3 mutant chains lacking the cytoplasmic tail can be found at the cell 
surface both in functional TCR/CD3  complexes and in a GPI-anchored monomeric form in- 
dicating that the cytoplasmic tail of the TCR[3 chain functions as an ER retention signal. The con- 
cordance between cell surface  expression of the mutant chains  as TCR/CD3 complexes and their 
capacity to mediate thymocyte differentiation supports the CD3 mediated feedback model in 
which  preTCR/CD3  complexes control  the  developmental transition  from CD4  CD8-  to 
CD4+CD8 + thymocytes. 
T 
he oL and  13 chains of the TC1L play a central role in 
the development of or[3 T  cells  (1-3). Both chains are 
members of the  Ig superfamily and  are  encoded  by gene 
segments that undergo rearrangements during T  cell differ- 
entiation  to yield functional genes  (4).  Rearrangement of 
both, TC1K and Ig genes, requires the expression of the re- 
combination activating genes RAG-1 and RAG-2 (5, 6). 
During T  cell  development, rearrangement at the TClK[3 
locus precedes rearrangement at the TC1Lo~ locus (7, 8).  In 
transgenic  mice,  expression  of a  functional  TC1K[3 trans- 
gene was shown to block rearrangement and expression of 
endogenous TC1K[3 genes, indicating that TC1K[3 genes are 
subject  to  allelic  exclusion  (9).  Expression  of the  TC1K[3 
protein was shown to be required for mediating allelic  ex- 
clusion  at  the  TC1L[3  locus  (10).  However,  a  mutant 
TCRI3 chain lacking the variable domain (AV-TCP.[3), ef- 
ficiently blocks rearrangements of endogenous  TCP-13  al- 
leles, while leaving recombination of the TCRo~ genes un- 
impaired (10,  11). 
How does a TC1K[3 chain block V-DJ rearrangements? 
Studies in TC1K[3 transgenic mice are most consistent with 
the  feedback model,  first proposed for allelic  exclusion at 
the  Ig heavy chain locus  (12).  Before rearrangement at Ig 
light  chain  loci,  Ig heavy chains  assemble with  surrogate 
light  chains  (VpreB  and  h5)  as  well  as  mb-1/B29  het- 
erodimers  (13-16).  This pre-B cell receptor complex ap- 
pears at very low levels at the cell surface and is thought to 
induce  the  development from pro-B  cells  to  pre-B  cells, 
concomitant with  the  shut  off of the  Ig heavy chain  loci 
through specific target elements (17-20). The identification 
of a surface-expressed pre-T cell receptor complex analo- 
gous to the pre-B cell receptor complex, has allowed ex- 
tension of this model to the T  cell lineage (21-24). Early in 
pre-T cell development, the pre-TCP, complex is thought 
to signal a functional V-DJ rearrangement,  impairing fur- 
ther V-DJ rearrangements.  As is  clear from studies  of re- 
combination-deficient mice reconstituted with a functional 
TCR[3 transgene (3,  22,  25)  or with a mutant AV-TCR[3 
transgene  (26),  the  pre-TCR  complex  appears to  be  in- 
volved in  further  differentiation  of pre-T  ceils  including 
downregulation  of the  interleukin  2  receptor o~  (IL2-Ro  0 
chain,  upregulation  of CD4  and  CD8  coreceptors,  en- 
hanced transcription at the TCRo~ locus and expansion of 
the thymocytes to normal numbers. More recently, a novel 
33-kD glycoprotein (pTot) has been identified as the bind- 
ing partner of the TCR[3 glycoprotein. This heterodimer is 
found at very low levels at the  cell surface of pre-T cells 
(27).  Subsequent  cloning  and  gene-targeting  of the  pTot 
gene in mice demonstrated the crucial role ofpreTot chain 
in pre-T cell development (28,  29). 
Evidence for an important role of CD3  components in 
signal  transduction  by  the  pre-TC1L/CD3  complex  has 
been provided (26,  30,  31).  CD3  components are present 
at  the  surface  of developmentally arrested  thymocytes of 
RAG-deficient mice in the absence of TC1K chains. Cross- 
linking  of the  CD3  modules  on  differentiation  arrested 
CD4-CD8- thymocytes of RAG-l-/-  mice in vitro  (30) 
or in vivo (26,  31) with anti-CD3~ mAb induces the tran- 
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Volume 184  November 1996 1833-1843 sition from  CD4-CD8-thymocytes to  CD4+CD8 + thy- 
mocytes,  concomitant with  all  the  changes  described for 
recombination-deficient mice  reconstituted  with  a  func- 
tional TC1K~  transgene or  the  mutant AV-TCR[3 trans- 
gene (see above). Thus, cross-linking of the CD3 modules 
on CD4-CD8-  thymocytes apparently mimics the signal- 
ing mediated by the pre-TCR complex. 
Earlier experiments have shown that the variable domain 
of the  TC1K[3  chain is  not reqmred  to  induce early thy- 
mocyte development (10,  11,  26).  To  determine the  do- 
mains required to induce pre-T cell development, we have 
generated  five  different  mutant  TC1K~  transgenic  mice 
with defined alteration in the TC1K~ constant region. 
Materials  and Methods 
Construction of Mutant  TCR  Transgenes 
Starting material for the construction of the ~8313~3A, i3i3i3otot, 
[3ototl3[3, and 13otototot mutants (see Fig.  1) was a 20-kb Asp 718 
(KpnI) TCR~ fragment from the cosmld clone cosHYI39-1.14-5 
(9).  Mutanons were  restricted  to  the  6.1-kb BamHI  fragment 
containing all the tour exons  of the C~2 constant region; tran- 
scriptional control elements such as the TCRI3 promoter and the 
3' TCR[3 enhancer region as well as the functional VDJ region 
were not altered. 
Construction of a Mutant TCR~  Transgene Lacking the Cytoplas- 
mic Tail (~A).  The i3i313~A protein was generated by con- 
vert]ng the 2rid  codon of the  4th TCR~ constant exon into a 
TAG stop  codon that deletes  three lysmes, an asparagine and a 
senne. After three sequential subclomng steps, first a 6.1-kb Ci32 
BamHI fragment, second a 1.940-kb PstI-HpaI fragment and third a 
322-bp EcoRV fragment containing the TCR~ constant exon 4 
encoding the putative cytoplasmic  tall of the TCR~ chain was 
cloned  into  pSP72.  By  recombinant PCR  the  second  codon 
AAG was mutated into a TAG stop  codon, which introduces a 
XbaI resmctlon site (TCTAGA). 
Two recombinant PCR primers, anti-sense (as) and sense (s), were 
used in combination  with T7- and SP6-speclfic primers, respectively. 
Primer T7, 5'-AAATTAATACGACTCACTATAGGG3'.  Primer 
SP6, 5'-ATACACATACGATTTAGGTGACAC-3'.  Primer as, 
5'-C  TCAGGAATTTTTTTTCTAGACCTGAGAAAGAGA- 
AGA  C-Y.  Primer  s,  5'-GTCTTCTCTTTCTCAGGTCTA- 
GAAAAAA  TTCCTGAG-3  '. 
PClq, products were digested  with XbaI and EcoP,.V restric- 
tion endonucleases yielding a 199-bp and a 123-bp XbaI/EcoRV 
fragment.  These fragments were cloned into the polyclonmg sites 
of the pSP73 and pSP72 vectors respectively (Invltrogen, San DI- 
ego, CA). These plasmids were digested with XbaI and BglI and 
the appropriate  fragments  were ligated  to  generate  a pSP72/73 
hybnd vector containing the mutated 322-bp EcoP,  V fragment. 
Presence  of the mutation was verified  by sequencing. The rein- 
sertion of the mutated 322-bp EcoKV fragment into the 20-kb 
Asp718 fragment was analogous to the subclonlng procedure de- 
scribed above. 
Construction of Mutant  TCRot/~  Chimeric Transgenes ¢3~¢3otoe, 
tBaotjS~, flotototoe.  To  generate  the  [3otototot TCR  chimeric 
gene, a 6.1-kb BamHt fragment containing the complete TCR.~ 
constant region (C[32) was replaced  by the  8.6-kb BamHI ge- 
nomic fragment from the cosm]d clone cos H-Yot9.1-36 which 
contains the TClq.ot constant region (Cot). Orientation was deter- 
mined by ClaI and EcoRI digestions  (see physical maps in refer- 
ences 9, 32). For the [3otot[3[3 and f3f3ototot TCR chimeric genes, a 
5' and a 3' fragment of the C[32 and Cot fragments were cloned 
into pSP72  or pSP73 respectively  (Invitrogen). The 5' fragments 
contain exon 1 and 2, and the 3' fragments contain exon 3 and 4 
of the TC1K constant regions.  These plasmids were digested with 
PvuI and partially with BglI1 and the appropriate  fragments were 
llgated  to  obtain the 8.2-kb 5'C[3-3'Cot and the 6.5-kb 5'Cot- 
3'C[3 hybrid-fragments flanked by BamHI sites. This step intro- 
duces a BgllI-EcoRV-ClaI-EcoI linker from the polycloning site 
of the  pSP plasmids.  Replacement of the  6.1-kb C[32 BamHI 
fragment  from  TCR[3  with  the  5'C[3-3'Co~  and  5'Cot-3'C~ 
BamHI  hybrid-fragments  generates  the  [3[3~otot and  [3ototiB[3 
TCR transgenes,  respectively.  A 200-bp BamHI fragment 5' of 
the 6.1-kb C~32 intron fragment was deleted at this step. Orienta- 
tion was determined by ClaI digestion. 
Construction of the ~3~3-PI Transgene.  Starting material for this 
mutant transgene was a 20-kb Kpnl fragment harboring the func- 
tional TCIM3  gene of the  encephalomyehtogenlc T  cell  clone 
cloned Into k Charon 39 (33). In brief, the TC1M3 insert was &- 
gested to completion with BamHI. Three of the resulting restric- 
tion fragments  were then subcloned into pKS(-)  (Stratagene);  a 
8.3-kb BamHI fragment containing the  functionally rearranged 
VDJi3 (pTCRI3 8.3),  a 7.3-kb BamHI fragment containing the 
genomic C[32 region (pTCRIB  7.3)  and a 4.7-kb BamHI-KpnI 
fragment containing the Yend of the phage clone (p4.7 kb). Site- 
directed mutagenesis was performed on the pTCR~ 7.3 subclone 
to introduce an AccI restriction s~te 39 bp 3' of the start of the 
TM exon of C[B2 by using oligonucleotide-dlrected  m vitro mu- 
tagenesis (Amersham Corp., Arlington Heights,  IL); the resulting 
clone  was  called  pC~2Accl.  A  2.3-kb  BamHI-SacI  fragment 
from pTCR[3 7.3  containing the first exon of C~2  (lg-hke re- 
gion), a 687-bp SacI-AccI  fragment from pC[3Accl  containing 
the 2nd exon (encoding the connecting peptide)  of C~2 and the 
first 13 aa ofexon 3 of q32 encoding part of the TM region, and 
a  1.4-kb AccI-BamHI fragment from  Q72-6-220ApBG (a  gift 
from Dr.  Gerry Waneck, Massachusetts General Hospital, Boston, 
MA) containing the Q7  b pI anchor signal and SV40 poly adeny- 
lation signal was ligated into BamHI digested pKS(-)  to generate 
pC~2PI. To construct the mutated TC1M3 transgene used for in- 
jection a  tnmolecular ligation was  performed with  the  8.3-kb 
BamHI fragment from pTCRI3 8.3, the 4.4-kb BamHI fragment 
pC[32PI, and BamHI hnearized dephosphorylated p4.7  BK plas- 
mid. The resulting construct pTgCI32PI was checked for orienta- 
tion of the respective  fragments relative to each other by restric- 
tion mapping. An N17-kb NotI-KpnI restriction fragment was 
prepared from pTgCi32PI  and used for the production of trans- 
genic mice. 
Transgenic  Mice 
Fertilized mouse oocytes were recovered in cumulus from the 
oviducts ofsuperovulated females that had mated with FVB males 
several hours earher. The DNA-fragments  (2-4 Ixg/ml 10 mM Tris- 
HC1/0.1  mM EDTA [pH 7.5]) were injected into the most ac- 
cessible pronucleus of each  fertilized  egg essentially as described 
(34).  After  overnight culturing, 2-cell stage embryos were  im- 
planted into the oviducts of day 1 pseudopregnant C57B1/6 foster 
animals and carried  to  term.  Several weeks  after birth total  ge- 
nomlc DNA was prepared  from tall biopsies  as  described  (35). 
Transgemc founders were  crossed with FVB mice. To exclude 
insertion specific phenotypic effects, mice derived from three to 
six different founder lines were analyzed for each construct. The 
generation of TCR~  (~3/313~[3) transgenic  mice  has  been  de- 
scribed (9). 
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For Southern blot analysis 10 Izg of total genomic DNA of each 
mouse was chgested  with restriction enzymes as recommended by 
the suppher, separated on 0.6% agarose gels, and transferred to ni- 
trocellulose.  Filters  were  hybndized  to  32p-labeled probes  and 
washed as described (36). Probes used for DNA analysis were V[38.1 
(37)  and J[32  (38).  The final wash was  at 0.1X  SSC,  60°C and 
0.1 X SSC, 42°C, respectively. 
For Northern blot analysis 20 Izg of total RNA,  prepared by 
the  L1Cl-urea method,  was  separated  on  1%  agarose-formalde- 
hyde  gels  and transferred to  nylon membranes (39).  Probes  for 
V[38.1  (37),  Cot (40),  C[3  (41),  and actine (42)  were 32p-labeled 
by random pnming, hybridization conditions were  as described 
(36) with the addition of 1% SDS to all solutions. The final wash was 
at 0.1 X  SSC, 60°C. Filters were exposed with Kodak X-Omat S 
or XAR-5 films at -70°C using intensifier screens. 
Phospholipase  C  Treatment of Thymocytes 
Thymocytes  from  [3[36]3[3, [36]3[3A, and  [3]3[3-PI transgenic 
mice (106/ml) were Incubated for 40 min at 37°C in complete Is- 
cove's medium rather in the presence or absence of 1 U/ml phos- 
pholipase C  (PLC) 1 (isolated from Bacillus cereus). 
Antibodies and Immunofluorescence 
Ann-CD3e  145-2Cll  (43),  antl-TCR[3 mAb H57-597  (44), 
anti-V[36 mAb 44-22-1  (45),  and anti-V~8 mAbs KJ16-133 (46) 
and F23.1 (47) were purified from culture supernatants by HPLC. 
Punfied Ig and FITC- or biotin-conjugates thereof were used for 
immunoprecipltanon and lmmunofluorescence analysis as  indi- 
cated.  The  mAbs directed  against CD4  (clone 1KM-4-5),  CD8 
(clone  53-6.7)  and  V[32  (clone  B20.6)  were  purchased  from 
PharMingen.  Flow  cytometry  was  performed  on  a  FACScan  ® 
(Becton  Dickinson, Mountain View,  CA),  using Lysls  II  soft- 
ware.  For  double labeling FITC- and PE  or bmtin-conjugated 
mAb  were  used.  Cells  incubated with  biotin-conjugated mAb 
were  subsequently  stained  by  incubation with  PE-conjugated 
streptavMin. Data are depicted as contour plots (log density 50%, 
threshold 1%,  1 ×  smoothed) or dot plots. 
Radiolabeling,  Immunoprecipitation,  and Gel Electrophoresis 
For metabohc labeling splenocytes of transgenic and non-trans- 
gemc FVB mice were cultured in 15 ml Iscoves medium supple- 
1Abbreviations used m this  paper. GPI, glycosyl-phosphatidyhnos,  tol; PLC, 
phosphohpase C 
mented with Con A and 10% FCS. After 3 d, activated lympho- 
cytes were  xsolated  on a  density gradient. B  cells  were  depleted 
with sheep ann-mouse Ig coupled to magnetic heads, according 
to  the  manufacturers  procedure  (Advanced  Magnetics,  Cam- 
bridge,  MA).  Enriched T  lymphocytes were  washed  twice  and 
starved for  1 h  in methionine-free RPMI-medium (Selectarmne 
kit;  GIBCO BRL,  Galthersburg, MD)  supplemented with  10% 
dialyzed serum and counted. Lymphocytes  (20-30  ×  106) were 
labeled metabolically for 4  hours with  100 }xCi [3SS]methionine 
in 1 ml methionine-free RPMI-medlum in a humMlfied incuba- 
tor at 37°C, 5% CO2. Subsequently the cells were harvested and 
lysed for 30 min at 4°C in NP-40 containing lysls buffer (50 mM 
triethanolarmne-Cl, pH 7.5, 5 mM MgCl2, 1 mm PMSF, and 0.5% 
NP-40).  Nuclear  debris was  removed by  centrifugatmn for  15 
min at 13,000 g. 
Surface iodinanon, lmmunopreclpitatmn, SDS-PAGE, and au- 
toradiography were carried out as described (11). 
Results 
The Experimental System.  To  dissect the  domains within 
the  TC1K[3  constant region which  are  required to  induce 
pre T  cell development, five different mutant TCIK[3 chain 
genes were constructed. The structure of each mutant TC1K 
transgene product is illustrated in Fig.  1. 
For transgenesis, the FVB mouse inbred strain was used. 
FVB mice lack V[38 segments as demonstrated by Southern 
blot  and  flowcytometric  analysis,  allowing specific  detec- 
tion  of the  V[38.2  domain  common  to  all  mutant  TCR 
chains. To investigate whether the V[38.2  domain had any 
detrimental  effects  on  T  cell  development  in  the  FVB 
background,  e.g.,  by VI38-specific superantigen(s),  TCR[3 
transgenic C57B1/LiA  mice were  crossed with  FVB  mice. 
The  T  cell  compartments  in  TCR~  transgenic  FVB  × 
C57B1/LiA  F1  and  C57B1/LiA  mice  did  not  show  any 
changes  in  the  size  of V~8.2 +  T  cell  subsets  in  thymus, 
spleen and lymph nodes (data not shown). 
Expression  of the  mutant  transgenes  was  determined 
by Northern blot analysis using total RNA  extracted from 
spleens of different founder lines and a V~8 specific probe. 
The 3' untranslated region of the TCRot mRNA  is ,--,200 bp 
longer than that of the 3' untranslated region of the TCR]3 
message,  whereas  these  two  mRNAs  are  similar in length 
Protein Domains  TCROt TCR~  Mutant TCRI~ Transgene  Products  Figure  1.  Schematic  illustra- 
tion of the proteins  encoded  by 
the  mutant  TC1K transgenes. 
TC1K~ protein (eaxtx~, dashed) 
and  TCRD  protein  (1313131313, 
black)  share  a  common  basic 
5-domain structure:  V,  variable 
domain;  Ig, lg-like domain; CP, 
connecting peptlde,  TM,  trans- 
membrane region; CT. cytoplas- 
mic tall. Beside the non-mutant 
TCIK[3 transgene and the mutant 
A~[3[3[3 cham, five additional alterations were introduced into the TCR~ constant regions. The ~]3[3[3A mutant resembles a TCR[3 protein lacking its 
cytoplasmic tail and the ]3]3[~-PI mutant comprises the three extracellular constant regions of the TCRI3 chain and the first 13 aa of the TCR[3 trans- 
membrane region connected to the Pl-anchor sequence of Q7  b. The 13[3]3cax, ~tx0t[3~, and ]3~x~xotct mutants were generated by domain swapping. The 
first ~ resembles the TCR]3 variable domain, the second, third, fourth, and fifth letter mdmates the origin of the extracellular constant Ig-hke domain, 
the connecting peptlde, the transmembrane region and the cytoplasmic tad, respecnvely. A in&cates deletion of that particular region. 
1835  Jacobs et al. A 
1'~'1  +1  ¢Q"  I  =.  =.  ,  , 
I~...I ~'1  ~  I  .~  ~.,  ,.~  ~  I  ~  I  ,,.,.-, 
..~1  I~_.  ~  I  cQ.  t  2~:~  3  I  ~Q"  ..~=  ~__.~=.2_~  2=1  2  3~1  411  2  3 
TCR V~8 
TCR Cet 
B 
nTg  BBBB8  8BBoca. 
d  i  & 
Figure  2.  Expressmn of the 
~,,e~  I~.~=a  mutant  TCR  transgenes.  (A) 
!  ~  --~IXl  Northern  blot  analysis to study 
:~  expression of the  mutant TCR. 
,  -- 07  transgenes.  Total RNA extracted 
~  from spleens of &fferent mutant 
-~8  TCP-  founder  lines was  ana- 
~  lyzed for the presence of trans- 
-4a  gene  specific transcripts  RNA 
i  ~  samples  from  non-transgenlc 
FVB  m~ce (wt), Af3131313 trans- 
gemc mice and [~[~[~/A[~[~[~[~ 
~*  ~  --  29  double-transgemc  mace are  in- 
cluded  as  controls. Northern 
blots were hybnchzed  with V[38-, 
--  18  constant  TCR  Cot-, and TCI:L 
C[3-speclfiC probes  (B)  SDS- 
PAGE  analysis  of  anti-V[38 
--  14  lmmunopreclpltates from meta- 
bohcally labeled Con A blasts of 
mutant  TCR  transgemc m~ce. 
V[38-spec~fic mamunoprec~p~tates 
from NP40 lysates of metaboli- 
TCR Cl8 
cally labeled Con A blasts derived from splenocytes  ofa non-transgenlc FVB mouse (nTg)  and mutant TC1L transgenic mace were analyzed  under reduc- 
ing condinons by SDS-PAGE analysis on a 10-15% gra&ent gel. Arrow heads ln&cate the different glycosylatmn  forms of the mutant TCR chains. 
Contammanng ~mmunoglobulin  hea  W and hght chain (H and L) are due to m&rect preclpltauons with rabbtt ant1 mouse Ig. A mdxcates the posmon of 
actln. The position of  molecular weight markers are ln&cated (kD). 
in  the  other  regions.  As  expected,  [31313ota and  [3otototot 
transcripts  co-migrated  at  the  position  of mature  TCP,  xx 
transcripts  (1.5 kb)  whereas  the  [3131313A and ]30t~x~  tran- 
scripts run at the position of mature TC1M3 transcripts  (1.3 
kb). The size of the [31313-PI  mRNA was also in accordance 
with the structure of the ~[313-PI transgene (not shown). Hy- 
bridizauon patterns  with 32p-labeled probes specific for the 
TCRot  and  TClq.[3  constant  regions  were  in  accordance 
with  the  structure  of the  TCR.  or/13 chimeric  transgenes. 
The lack of detection  of endogenous TCR[3  transcripts  is 
not due to allelic exclusion but to the relatively short expo- 
sure  of the  autoradiograph  in  view  of the  relatively  high 
expression of the mutant TCR[3 transgenes (Fig. 2 A). 
Expression of the mutant TCR  chains was further deter- 
mined  by  SDS-PAGE  analysis  of VB8-specific  immuno- 
precipitates  from  NP40-1ysates  of  metabolically  labeled 
Con A  activated  splenocytes.  T  cell  enriched  splenocytes 
from  non-transgenic  FVB  mice  and  transgenic  [3[3[3[3[3, 
[3[3~3cxet, [3o~c~[3,  and  ~otomm~ mice were  used.  Immuno- 
precipitates  were  analyzed under reducing conditions on a 
10-15%  SDS-PAGE  gradient  gel.  Whereas  T  cells  from 
FVB mice lack V[38-specific polypeptides, the T  cells  from 
the  TCP,.~  mutant  mice were  found to  express  anti-V[38 
reactive glycoproteins of the expected sizes (Fig. 2/3). 
The  t~Scee~  Transgene  Perturbs the  Transition from  the 
CD4- CD8- Stage to the CD4  ÷  CD8  + Stage.  To  study  the 
effects  of the  different  mutant  TC1L  transgenes  on  thy- 
mocyte  development,  we  first  compared  the  number  of 
thymocytes  found  in  different  mutant  transgenic  lines. 
With  the  exception  of 131313omt transgenic  mice,  the  abso- 
lute  number  of thymocytes in  the  mutant  transgenic  lines 
was comparable to that of non-transgenlc mice (Fig.  3 A). 
In 131313c~cx transgenic mice the number of thymocytes was 
reduced to 36  2  8 %  (n  =  6) compared to non-transgenic 
control littermates  (n =  7).  To assess which developmental 
stages were affected by the expression of the [313~&e~ chain, 
we  determined  the  size  of the  different  CD4/CD8  thy- 
mocyte compartments of control and mutant mice (Fig. 3, 
B  and D).  Although the  absolute  number of CD4-CDS- 
thymocytes  in  [31313otot transgenic  mice  was  normal,  the 
number of the CD4+CD8 +, CD4+CD8  and CD4-CD8 + 
subsets  were  clearly  reduced,  suggesting  that  the  [31313aot 
chain  interferes  either with  the  expansion  of CD4+CD8 + 
thymocytes or with  the transition  of thymocytes from the 
CD4-CD8  to the  CD4+CD8 + stage.  Mature  ot~  T  cells 
were  significantly  reduced  in  thymus,  lymph  nodes  and 
spleen of ~[313oux transgenic mice  (Fig. 3,  C  and D).  In all 
other  mutant  transgenic  lines  analyzed,  the  different  thy- 
mocyte compartments  were  comparable  to  those  of non- 
transgenic FVB mice (Fig. 3, A-D). 
Usage of Endogenous  V¢I  Gene  Segments in  Mutant  TCR 
Transgenic Mice.  Two  color immunofluorescence  analysis 
using anti-V[32  and anti-V[36 mAbs was performed  to  as- 
sess  functional  rearrangements  of endogenous  alleles.  In 
non-transgenic FVB mice the eq3 T  cell subsets expressing 
VI32- and V[36-domains represent  13.8  --- 0.7 % and 9.8  + 
0.6  %  (n  =  28)  of mature  peripheral  et[3 T  cells,  respec- 
tively (Fig. 4). 
However,  in  13131313A transgenic  FVB  mice  the  V132  + 
and V[36  + subsets  constituted  oMy 0.2  --  0.1%  and  1.7  _+ 
0.8  %  of mature  c~[3 T  cells,  respectively  (n  =  12).  These 
data strongly suggest that the 13131313A  mutant protein product 
efficiently prevents  rearrangements  of endogenous  TCR[3 
alleles.  Based on the usage of VI32 and VI36 gene segments 
in control FVB mice,  the efficacy with which the 13131313A 
transgene prevented surface expression of rearranged V[32- 
and V[36-gene segments was 99% and 83%, respectively. 
In  [3[3~otoL transgenic  FVB  mice,  the  VI32-subset corn- 
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Figure  3.  Quant]atlve  com- 
parison  of the  etl3 T  cell  com- 
partment in mutant TCtl. trans- 
genlc trace.  (A) Relative number 
of thymocytes  in  mutant TCR 
transgenlc mace. The number of 
thymocytes  was  detenmned  by 
flow  cytometry  on  a  Sysmex 
F800 and compared to nontrans- 
genic  httermates  and/or  age 
matched FVB  mace. In  [3[3[3(x(x 
transgenlc  mace the  number  of 
thymocytes was found to be re- 
duced  to  36  -+  8%  of control 
mace. The thymocyte cellularity 
in  all  other  mutant  transgenlc 
mace, mcluchng the [3[313-PI  trans- 
geracs (not shown) does not dif- 
fer from non-transgemc httermates. 
Number below each bar indicates 
the number of mace analyzed. (B) 
CD4/CD8  thymocyte  subsets in 
mutant  TCR.  transgemc  mice. 
The percentage of CD4- CD8 
double-negative  (DN),  CD4 + 
CD8 + double-positive (DP)  and 
CD4+CD8  or CD4  CD8 + sin- 
gle positive (SP) thymocyte sub- 
sets  compared  to  the  absolute 
number in FVB controls are de- 
picted.  The  subsets  were  mea- 
sured by two-color immunofluo- 
rescence and analyzed using Lysls 
II  software  (Becton D]ckinson). 
Although  the  number  of  DN 
pro-thymocytes  is  normal  m 
B]3[3cm~  transgemc  mice,  the 
number of DP and SP are sigmfi- 
cantly reduced. Numbers below 
each bar indicate the numbers of 
mace analyzed.  (C3  N3f3c~a trans- 
gemc  mace lack  mature  T  cells. 
The percentage  of mature T  cells 
m thymus, lymphnodes and spleens 
was determined by lmmunofluo- 
rescence analysis with anti-CD3e 
and  ann-TC1K[3  mAbs.  A  sys- 
temic reductmn of mature o~[3 T 
cells was found In [3[3[3~x0¢  trans- 
genIc mice. Numbers below each bar indicate the numbers of mice analyzed  (D) Two-color lmmunofluorescence analysis of thymus, spleen and lymph 
nodes with CD4/CD8 or CD45I~/TCP,.o~ specific mAbs. Typical examples  of non-transgenIc FVB control mice and transgenlc ~A  and 13~[3c~cx 
mice are shown. Whereas the numbers and subsets of immature and mature o~13T cells are comparable In non-transgenlc FVB control mice and transgenIc 
131313~A mice, transgenlc  mice expressing the 131313c~c<  chain have a systennc reduction of mature T cells  Numbers in each quadrant in&cate percentages. 
prised 5.6  +  0.9 %  (n =  6),  a value significantly lower than 
the  13.8  +  0.7  %  observed  in  nontransgenic  FVB  mice. 
However,  the  frequency  of VI36 + T  cells  was  not  signifi- 
cantly  different  in  131313oco~ transgenic  mice  10.6  +  0.7% 
(n  =  6)  compared  to  the  FVB  control mice  (9.8  +  0.6%, 
n  =  28). 
Cell SuoCace Expression of  the Mutant TCR Chains.  Extremely 
high levels  of [3~[313A  and  [31313~PI chains were  found  on 
the  surface  of thymocytes  of [3131313A (Fig.  5)  and  [31313-PI 
transgenic  mice  (not  shown),  as  determined  by  flow  cy- 
tometry.  Low,  but  detectable  levels  of the  [31313omt chain 
were  found  on  the  surface  of  13~[3otot  transgenic  thy- 
mocytes  and peripheral T  cells  (Fig.  5).  The  latter also  ex- 
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press  high  levels  of  endogenous  TCR/CD3  complexes 
(Fig.  3  D).  The  products  encoded  by  the  [3c~ot~  and 
13otc~c~cx transgenes  could  not be  detected  at  the  surface  of 
thymocytes  and mature  T  cells as  determined  by flow  cy- 
tometry  with  a  VI38-specific  mAb  (data  not  shown).  The 
failure  of the  [3omq313 and  [3emtcmt mutant  TCR  chains to 
appear on the cell surface  could explain the absence of any 
observable effects on T  cell development  (Fig.  3) and usage 
of endogenous  TCR[3  V-gene  segments (Fig.  4). 
Disproportional Surface Expression of TCR¢i and CD3 Com- 
ponents on ~ISA  Thymocytes.  Two-color  immunofluo- 
rescence  analysis  of normal  thymocytes  using TCIL[3-  and 
CD3e-speclfic  antibodies  demonstrates  the  characteristic Percentage of  VI~ 6 positive peripheral T cells 
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Figure  4.  Frequencies of peripheral T cell subsets m mutant TCR[3 
transgenic rmce expressing V]32- and V[36- domains. The relative size of 
the VI32-  and VI36- T cell subsets was deterrmned by two-color flow cy- 
tometry and corrected for the percentage of  mature T cells, as determined 
by anti-CD3e and ant>TCR[3 stalnmg The number of n~ce analyzed is 
indicated below each bar; nd, not determined. Mice from three to six dif- 
ferent founder lines were included per mutant TCP,. construct. 
staining pattern for the e~JJTCR/CD3  complex, with pro- 
portional levels of TC1KI3 and CD3e components. Surpris- 
ingly,  the  surface levels  of 13[3[3[3A and  CD3e  are  dispro- 
portional  on  thymocytes  from  13[3~[3A mice  (Fig.  6  A). 
Immature (i.e.,  CD3  l°w and CD3  lnt) and mature  (CD3 high) 
thymocytes were  found to  express  the  [3[3[313A protein  at 
unusually high levels. 
The composition of the [J[313[3A/CD3 complex was fur- 
ther analyzed biochemically  (Fig.  6  /3). Analysis of CD3e- 
specific immunoprecipitates revealed a normal composition 
of disulfide-linked  0q3TClk  heterodimers  associated  with 
CD38,  CD3y,  CD3e,  and disulfide-linked  CD3~  compo- 
nents on thymocytes from non-transgenic  FVB, transgenic 
TC1K~  and  ~131313di mice.  Beside  normal  levels  of func- 
tional TC1K/CD3 complexes,  subsequent immunoprecipi- 
tations with anti-V138-specific mAbs indicated that 13J3JJl3di 
thymocytes express  high levels  of [313[313A monomers,  ap- 
parently in the absence of CD3 components. This explains 
the  disproportional  [313[J[3di/CD3  ratio  found on  131313~A 
transgenic thymocytes. 
Anchoring qfljS~8~fjfZl Monomers through Glycosyl-phosphati- 
dylinositol.  The possibility that anchoring occurred through 
glycosyl-phosphatidylinositol (GPI) was tested by incubat- 
ing thymocytes from [3[J[3JJA transgenic mice, and as a con- 
trol from j3[3[3[3[3 transgenic mice,  with  or without phos- 
phatidylinositol-specific PLC, which can specifically release 
GPI-linked  proteins  from  the  cell  surface.  Subsequently, 
the  cells  were  analyzed  for  surface  TCtk[3  expression  by 
E 
r- 
o 
thymus 
lymph  ~  ....... node 
anti-V~8 log fluorescence 
Figure 5.  Surface  expression of mutant TCP. chains. Thymocytes and 
lymphnode cells from non-transgenic FVB control mice (1) and trans- 
genic JJJJJJ(xtx (2) and 13131313A (3) mice stained with transgene-speclfic 
FITC conjugated antl-V~8 mAb. 
flow  cytometry.  Upon  PLC-treatment,  thymocytes  from 
13131313A transgenic mice revealed a staining pattern,  charac- 
teristic for thymocytes from control FVB mice and TClK[3 
transgenic mice (Fig. 7), indicating that the JJ~J3di mono- 
mers appear in a GPI-linked form at the cell surface. 
T  Cell Development  in RAG-1-deficient Mice Expressing the 
Mutant TCR~ Chains.  To study the effects of the mutant 
TCR  chains on T  cell development in the absence of en- 
dogenous TCtkcx or TCP,[3 chains, we introduced the mu- 
tant  transgenes  into  the  V(D)J  recombination-deficient 
RAG-1 -/- background  (5).  The  JJ1313~A chain appears  at 
the  cell  surface  and  was  found  to  efficiently  induce  thy- 
mocyte development, as indicated by CD4/CD8 induction 
and  expansion  of the  T  cell  pool  to  wild-type  numbers 
(Table  1 and  Fig.  8).  Like the  13[3~13A chain,  the  13fJlJ-PI 
chain  does  appear  at  the  cell  surface  but  does  not permit 
development of CD4-CD8-  thymocytes into CD4+CD8 + 
thymocytes in the RAG-1 -/-  background, indicating that 
surface  expression  of the  extracellular  TClK[3  domains  in 
the absence of the  transmembrane  region cannot promote 
this  step in thymocyte development. Thymocytes of {3JJ[3otot 
transgenic  RAG-1 -/- mice  expressed  low  but  significant 
levels of the 13[3~otot chain on the cell surface (Fig.  8/3).  In- 
terestingly,  7% of the  thymocytes from J3J3jJotot transgenic 
1KAG-1 mutant mice had a CD4+CD8 + phenotype. Thus, 
the  [31313otot chain  is  able  to  induce  the  transition  from 
CD4-CD8-  to  CD4+CD8 +  thymocytes causing the  for- 
mation  of a  small  but  significant  CD4+CD8 + thymocyte 
subset  (Fig.  8 A).  However,  the  13~[3o¢ot chain fails  to in- 
crease  the  number  of thymocytes  (Table  1).  The  ~otot[J[3 
and the [3ototomL  chains do not appear at the cell surface and 
do not promote thymocyte maturation  (Fig. 8). 
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Figure  6.  High levels of [3[3[3[3A monomers appear  at the surface of 
immature thymocytes  in the absence of CD3 components.  (/t)  Dispro- 
pomonal surface expression  of CD3e  and  TCR{3  on  thymocytes  from 
[3131313A transgenic mace. The unusually high levels of [3[3[3[3A chains on 
thymocytes  from [31313~3A transgenic  rmce are compared to CD3e levels 
by two-color lmmunofluorescence  analysis. Thymocytes from nontrans- 
gemc (contro  0 and 131313[3A transgemc mice were stained with FITC-con- 
3ugated anti-CD3e (145-2Cll)  and blotmylated  anti  TCtM3-(H57-597 ) 
mAbs. Blotmylated  H57-597 was detected with PE-conjugated streptavl- 
din  Numbers  in  each  quadrant  indicate  percentages.  (B)  SDS-PAGE 
analysis of sequential  anti-CD3~ and anti-V{38 lmmunoprecipltates  from 
surface lodmated thymocytes  from nontransgenic  FVB trace,  transgenlc 
[313131313 and  ~[3]3A mice. Thymocytes from nontransgemc  FVB mice 
(lanes 1), transgenic TCR[3 (lanes 2) and [313[3[3A mice (lanes 3) were sur- 
face  lodmated  and  lysed  in  digltomn  containing lysis buffer  (11). The 
composition  of the  CD3~  and  TCR[3  associated  components  of the 
c~[3TCR/CD3 complex were analyzed by sequential  ]mmunopreciplta- 
tions  with  CD3~  and  V{38 specific mAbs.  After  three  precleanng steps 
with normal  mouse  serum  (3rd  preclear),  CD3~ associated TCtL/CD3 
components  were lmmunoprecipitated  by two sequential lmmunopreclp- 
6 
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o 
anti-TcR~  log fluorescence 
Figure 7.  Release  of [3[~13~3A chains from the surface of [3[313]3A thy- 
mocytes  by phosphandyhnositol-specific  phospholipase  C  (PLC).  PLC- 
treated  (+PLC,  dashed  curve) and  mock-treated (-PLC,  solid  curve) thy- 
mocytes from ~313131313 and [3~3~3~3A transgenic mice (106/ml) were washed 
twice,  stained  with FITC-labeled antl-TCtL[3  antibodies,  and  analyzed 
with FACScan ® (Becton Dickinson). 
Discussion 
Previously, we have demonstrated  that  a  mutant  TCtL~3 
chain  lacking  the  variable  domain  (A[3[3[313)  can  induce 
thymocytes  to  differentiate  from  the  CD4-CD8-  to  the 
CD4+CD8  ÷  stage  (10,  26).  To  identify the regions within 
the  TCR[3  constant  region  required  for  this  step  in  thy- 
mocyte  development,  we  have  extended  the  mutational 
approach  by  generating  five  additional  TClk[3  transgenic 
mice  in  which  constant  region  domains  were  deleted  or 
exchanged  by  corresponding  regions  of the  TCIkci  chain. 
Although  all mutant  TClk  transgenes  are  highly expressed 
at  the  mtLNA  and  protein  level,  the  13cio~{3[3 and  the 
[3cloLc~o~ chimeric  chains  could  not  be  detected  at  the  cell 
surface of thymocytes and peripheral  T  cells. Both proteins 
share  a  variable  TCtL[3  domain  and  the  extracellular  con- 
stant  region of the TCRIx  chain,  including the connecting 
peptide which contains the cysteine residue  responsible for 
the covalent interchain bond with TClk[3.  The structure  of 
the  ~3clo~13~3 and  ~3c¢0¢c~o~ chains  might  not  allow  assembly 
with  endogenous  TCR  and  CD3  components  in  the  Elk 
and  subsequent  transport  to  the  cell surface  (48).  The  fail- 
ure of 13clo~[313 and  13o~ommL chains to appear  at the cell sur- 
face  can  explain  the  lack  of any  noticeable  effects on  thy- 
mocyte  development  m  [3cio~[313 and  [3om~cio~ transgenic 
mice, on both wild-type and RAG-l-/-  background. 
The  13[3[3ome chimeric  chain  resembles  more  closely  a 
TClk[3  chain  than  the  [3cic11313 and  [3o~o~c¢oL chain.  The 
ltatlons  with anti-CD3e (1st CD3e and  2nd  CD3e).  Any residual anti- 
CD3e mAbs were precipitated by an additional preclear step with protein 
A-Sepharose beads (Prot.  A).  Subsequently  any residual {3[31313A choans 
and  associated molecules  were precipitated  with F23.1 mAbs indirectly 
coupled by rabbit anu-mouse IgG to protein A beads (antl-V~38). Immu- 
noprecipitates  were analyzed  under  non-reducing and  reducing condi- 
tions. Molecular  mass markers are indicated.  The 25-30-kD species and 
bands larger than  60 kD found m all V~8-speclfic  immunoprec]pltations 
are lg-hght and Ig-heavy chains from contarmnatmg  B cells. 
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Figure  8.  (A)  Induction  of 
CD4  and  CD8  expression  on 
thymocytes  of  mutant  TCP, 
transgemc RAG- 1-deficient thy- 
mocytes.  Thymocytes  ~solated 
from  wild-type  (H/7),  RAG- 
1-deficient  (R.AG-1-;-) and the 
five  dafferent  transgemc  RAG- 
1-deficmnt  mice  (RAG-t-'- × 
mutant  TCR[3  transgene)  were 
double  stained  using  CD4-  and 
CD8-speclfic  mAb and analyzed 
by flow cytometry.  Numbers be- 
low  each  dot  plot  indicate  the 
absolute number of double-posl- 
nve thymocytes.  (B) Surface ex- 
pression of mutant  TCR[3 chains 
on  RAG-l-deficient  thymo- 
cytes  Thymocytes from  control 
RAG-l-deficient (solid hnes) and 
mutant  TCI~I3 transgemc RAG- 
l-deficient  mice  (dashed lines) 
were stained with H57-597  con- 
jugated to HTC or PE and ana- 
lyzed by flow cytometry. Shown 
are  representative  experiments 
All experiments were repeated at 
least four times and gave consis- 
tent  results  Similar  data were 
obtained when cells were stained 
with F23.1 (anti-V[38). 
[31313tio¢ chain, which contains the extracellular cysteine re- 
quired  for  covalent  heterodimerization  with  TCR.o~  and 
likely also with the pTci chain, appears at very low levels at 
the  cell  surface,  as  indicated  by  flow  cytometric  analysis. 
This  suggests  that  the  [3[3[3oto~ chain  participates  in  the 
TClq./CD3  complex.  However,  the  [313~0mt chain cannot 
fully substitute for the function of the TCI<[3 chain in pro- 
moting differentiation  to  CD4+CD8 +  cells and in mediat- 
ing  allelic  exclusion.  The  latter  was  indicated  by  the  re- 
duced usage of the V[32 gene segment in mature  T  cells of 
~13otot  transgenic  mice.  Mature  thymocytes  expressing 
high  [313[3otot TCR/CD3  levels were not detected.  Appar- 
ently,  [313[3(xot thymocytes  depend  on  a  non-mutant  en- 
dogenous  TCP,.~  chain to mature  into  single positive thy- 
mocytes. 
To  specifically analyze  the role of [3[3[3oLot in the  transi- 
tion  of thymocytes  from  the  CD4-CD8-  to  the  CD4 + 
CD8 + stage we determined the capacity of the [313[3c~o¢ chain 
to mediate thymocyte differentiation in 131313(i(x transgenic, 
RAG-l-/-  mice. Expression  of the ~[3130to~ chain induced 
the  developmental  transition  from  CD4-CD8-  to  CD4 + 
CD8 + cells as indicated by the presence of a low but signif- 
icant number ofCD4+CD8  + thymocytes in the compound 
mutant  mice,  whereas  such  cells were  not  found  in  non- 
transgenic  RAG-1 -/-  mice.  Thus,  the  131313omt chain,  al- 
though expressed at low levels at the surface ofthymocytes, 
probably  as  a  component  of the  preTCR/CD3  complex, 
can induce the expression of CD4  and CD8  receptors. 
Table 1.  Cellularity, Pre-T Cell Induction and Surface Expression 
in the Thymus of RAG-1 Mutant Mice Reconstituted with Mutant 
TCR Transgenes 
Total  Absolute  Surface 
Tram-  No. of  No. of  expres- 
gene  V  C  CP TM  CT  thymocytes  DP cells  slon 
[3131313A  [3  t3  13  [3  k  1.4 ×  108  1.3  ×  108  Yes 
131313ixix  13  13  13  cl  ix  1.9  ×  106  1.3  ×  105  Yes 
[3ixix[3[3  13  ix  ix  [3  [3  3.7  X  106  5.1  X  103  No 
~ixixotix  [3  ix  ix  ix  ix  7  X  10  s  2.5  X  103  No 
131313-PI  13  [3  [3  PI  2  X  106  2.5  X  103  Yes 
WT  13  [3  [3  [3  ~  1.6  X  108  1.3  X  108  Yes 
RAG-1  NA  2  X  106  2.5  X  103  NA 
A, Domain deleted,  * PI, Linked via Q7  b PI sequence. 
1840  TCR.]3 Chain Domains Controlhng Early Thymocyte Development The  [3131B~A transgene  functions  in  most  aspects  as  a 
normal  [313131313 transgene  as judged  by thymocyte  num- 
bers, size of the different CD4/CD8  subsets and induction 
ofpre-T cell development in [3[3f3[3A;RAG-1-/- mice. Al- 
lelic exclusion in [313~[3A transgenic mice appears to be ef- 
ficient as indicated by the virtual absence of T  cell subsets 
expressing rearranged endogenous VI32 and VI36 gene seg- 
ments  in  these  mice.  Thus,  the  cytoplasmic  tail  of the 
TCR[3 chain is dispensable for its role in these aspects of 
T  cell  development.  Remarkably,  beside  normal  surface 
levels of disulfide linked TCRo~/1313~A heterodimers as- 
sociated with  CD3  components,  [313~A  chains  appear at 
high levels as GPI bound monomers in the absence of CD3 
components on the surface of thymocytes and B  cells (data 
not shown).  Thymocytes are known to regulate their sur- 
face  levels  of  TCR/CD3  complexes  posttranslationally. 
Single subunits or partial complexes that are synthesized in 
excess are retained in the ER and degraded (49).  Previous 
studies have shown that retention of individual subunits of 
oligomeric receptors is controlled by ER  retention signals 
located in the cytoplasmic domain. A di-lysine motif at po- 
sition  -3  and  -4  or  -5  from the  carboxyl terminus has 
been shown to control receptor assembly by retaining un- 
assembled individual chains in the ER  (50,  51).  The cyto- 
plasmic tails of TCR[3 proteins harbor such a di-lysine ER 
retention  signals,  VKRKNS  in  C[31  and  VKKKNS  in 
C[32.  Indeed,  [31313[BA chains  can  escape  ER  retention, 
TCR/CD3  assembly and proteolytic degradation. 
In  normal  TCR[3  chains  GPI  linkage  might  be  pre- 
vented by the cytoplasmic tail.  Therefore, the cytoplasmic 
tail  of the  TCR[3  chain  which  is  encoded  by a  separate 
exon appears to be essential for determining the early pro- 
cessing  events  of unassembled  TCRI3  chains  rather  than 
being required for TCR/CD3  assembly and signaling thy- 
mocyte differentiation. 
When compared to nontransgenic littermates, the [B[3[3{x{x 
and  the  [3131313A transgenes  were  found  to  interfere  with 
the usage of the endogenous V~2 segment in the {xIBT cell 
lineage.  In all founder lines analyzed, the  [3[313{xot and the 
[3131313A transgenes consistently excluded endogenous V[32- 
gene segments more efficiently than endogenous V[36-gene 
segments. This phenomenon may relate to the position of 
the  V  segment in  the  TCR[3  locus  (52).  The V~2  gene 
segment is the most 5'  V~  segments, distal of the D[3/J[3 
clusters whereas  the  V~6  segment is  located  proximal to 
the  D[3/J[3  clusters.  The suggested processivity of the  re- 
combination  machinery  from 3'  to  5'  would  more pro- 
foundly affect VI3 genes lying distal from the DJ join (53- 
56).  Alternatively,  pre-T  cell  development  induced  by 
functional TCR[3 chains might signal the shut down of en- 
dogenous TCRI3 locl from 5' to 3', resulting in the prefer- 
ential rearrangement of V[3-segments lying proximal to the 
DJ region. 
In conclusion,  we have identified the extracellular con- 
stant domains and the transmembrane region of the TCP,13 
chain to be required for initiating pre-T cell development 
as demonstrated by the efficient allelic  exclusion of endog- 
enous  TCt<[3  alleles  in RAG-I +/+ mice and transition  of 
CD4-CD8-  to CD4+CD8 + thymocytes in ]313]3]3A-trans- 
genic  RAG-1 -/-  mice.  Allelic  exclusmn  and  pre-T  cell 
development is inefficient in transgenic mice expressing the 
[3[313otot chain.  Both  the  extracellular constant region  and 
the transmembrane region of the TC1K]3 chain, but not the 
variable domain and cytoplasmic tail, are required for its as- 
sembly with the other TC1K/CD3 components. The cyto- 
plasmic tail of the TC1K]3 chain appears to be essential for 
retention of the TCR[3 chain in the ER but not for signal 
transduction. The finding that only those mutants that the- 
oretically can form disulfide  bonds  to  the  pT{x chain  and 
assemble with CD3 components into a pre-TCR complex 
can  catalyze  the  transition  from  CD4-CD8-to  CD4 + 
CD8 + cells supports the notion that cell surface expression 
of the preTCK/CD3  complex is a prereqmslte for pre-T 
cell differennation (29). 
Heinz Jacobs and John Iacommi conmbuted equally to the work presented. The authors gratefully acknowl- 
edge Nel Bosme, Tanja Maitment and Loes Rijswljk for assistance in animal care, Eric Noteboom and Evert 
de Vnes for technical advice, and Jannie Borst for gifts of antibodies and critically reading the manuscript. 
Punfied PLC was kindly provided by Hidde Ploegh. 
The work described was supported by a grant from the Human Frontier Science Program to A. Bems and S. 
Tonegawa and a National Institutes of Health grant to S. Tonegawa. 
Address correspondence to Anton Berns, Division of Molecular Generics, The Netherlands Cancer Institute, 
Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. H. Jacobs' present address is Institute for Genet- 
ics, University of Cologne, Weyertal 121, 50931 Cologne, Germany. J. Iacomini's present address is Trans- 
plantation Biology Research Center, Massachusetts General Hospital, MGH East, Bmldmg 149-9019, 13th 
Street, Boston, MA 02129. 
Received  for publication 4June  1996 and in revised  form 3 September 1996. 
References 
1. Von Boehmer, H. 1990. Developmental biology ofT cells in 
T-cell  receptor transgenic  mice. Annu.  Rev.  Immunol. 8: 
53•-556. 
2.  Phllpott,  K.L., J.L. Vmey, G. Kay, S. Rastan, E.M.  Gardmer, 
S. Chae, A.C. Hayday, and M.J. Owen. 1992. Lymphoid de- 
velopment in mice congenitally lacking T  cell receptor 043- 
1841  Jacobs et al. expressing cells. &ience (Wash. DC).  256:1448-1452. 
3.  Mombaerts, P., A.R. Clarke,  M.A. R_udmcki, J. Iacomini, S. 
Itohara, J.J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M.L. 
Hooper, and S. Tonegawa. 1992. Mutations in T-cell antigen 
receptor genes ~x and [3 block thymocyte development at dif- 
ferent stages. Nature (Lond.).  360:225-231. 
4. Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen recep- 
tor genes and T-cell recognitmn. Nature (Lond.).  334:395-402. 
5.  Mombaerts,  P.,  J.  Iacomlm,  R_.S. Johnson,  K.  Herrup,  S. 
Tonegawa, and V.E. Papaioannou. 1992. R.AG-1 deficient mice 
have no mature B and T lymphocytes.  Cell. 68:869-877. 
6.  Shmkai, Y., G. Rathbun, K.-P. Lam, E.M. Oltz, V. Stewart, 
M. Mendelsohn,  J. Charron, M. Datta, F. Young, A.M. Stall, 
and F.W. Alt. 1992. RAG-2-deficient  mice lack mature lym- 
phocytes  owing to inability to inmate V(D)J rearrangement. 
Cell.  68:855-867. 
7.  Furley,  A.J.,  S.  Mlzutani, K.  Weilbaecher, H.S.  Dhahwal, 
A.M.  Ford,  L.C.  Chan,  H.V.  Molgaard,  B.  Toyonaga, T. 
Mak, P.  Van den Elsen et al.  1986. Developmentally regu- 
lated rearrangement and expression of genes encoding the 
T cell receptor-T3 complex. Cell. 46:75-87. 
8. Born, W., E.  Harris,  and C.  Hannum. 1987.  Ontogeny of 
T-cell receptor gene expression.  Trends  Genet. 3:132-136. 
9.  Uematsu, Y., S. tkyser, Z. Demblc, P. Borgulya, P. Kfanpen- 
fort, A. Berns, H. von Boehmer, and M. Steinmetz. 1988. In 
transgemc  mice the introduced functional T  cell receptor [3 
gene prevents expression  of endogenous [3  genes.  Cell.  52: 
831-841. 
10. Knmpenfort, P.,  F.  Ossendorp, J.  Borst,  C.  Melief,  and A. 
Berns.  1989. T  cell depletion in transgenlc  mice carrying a 
mutant gene for TCP-.-[3. Nature (Lond.).  341:742-746. 
11. Ossendorp, F., H. Jacobs,  G. Van der Horst, E. De Vries, A. 
Berns,  and J.  Borst.  1992. T  cell  receptor--{x[3 lacking the 
[3-chain V  domain can be  expressed  at  the  cell surface but 
prohibits T cell maturation./. Immunol.  148:3714-3722. 
12. Yancopoulos, G.D.,  and F.W.  Alt.  1985.  Developmentally 
controlled and tissue specific expression of unrearranged VH 
gene segments.  Cell.  40:271-281. 
13. Pillai,  S.,  and D.  Baltimore.  1987.  Formation of disulfide- 
linked 1*2~p2 tetramers  in pre-B cells by the 18k ~p-lmmuno- 
globulin light chain. Nature (Lond.).  329:172-174. 
14. Tsubata, T., and M. 1Leth. 1990. The products ofpre-B cell- 
specific genes  (k5  and VpreB)  and the  Immunoglobulin Ix 
chain form a complex that is transported to the cell surface..]. 
Exp. Med.  172:973-976. 
15. Karasuyama, H., A. Kudo, and F. Melchers.  1990. The pro- 
teins encoded by the VpreB  and k5 pre-B cell-specific genes 
can associate with each other and with }x heavy chain..].  Exp. 
Med.  172:969-972. 
16. Brouns, G.S., E. De Vries, C.J.M.  Van Noesel,  D.Y. Mason, 
R_.A.W. Van Lier,  and J. Borst.  1993. The structure of the 
Ix/pseudo  light chain complex on human pre-B cells is con- 
sistent with a functmn in signal transduction. Eur. J. Immunol. 
23:1088-1097. 
17. Ferner, P., B. Knppl, T.K. Blackwell, A.J.W. Furley, H. Suh, 
A. Wmoto, W.D. Cook, L. Hood, F. Costantlm, and F.W. 
Alt.  1990. Separate elements control DJ and VDJ rearrange- 
ment in a transgemc  recombination substrate.  EMBO  (Eur. 
Mol. Biol.  Organ.).].  9:117-125. 
18. Serwe, M., and F. Sablitzky. 1993. V(D)J recombination in B 
cells Is impaired but not blocked by targeted  deletion of the 
lmmunoglobulin heavy chain enhancer. EMBO  (Eur.  Mol. 
Biol.  Organ.)J.  12:2321-2327. 
19. Lauster,  R.,  C.A.  Reynaud, I.L.  Martensson, A.  Peter,  D. 
Bucchini, J. Jami, and J.C. Welll. 1993. Promotor, enhancer 
and silencer elements regulate rearrangement of an lmmuno- 
globulin transgene.  EMBO  (Eur.  Mol.  Biol.  Organ.)J.  12: 
4615-4623. 
20. Chen, J., F. Young, A. Bottaro, V. Stewart,  R.K. Smith, and 
F.W. Alt.  1993. Mutations of the intronic IgH enhancer and 
its flanking sequences differentially affect accessibility of  JH lo- 
cus. EMBO (Eur.  Mol.  Biol.  Organ.)J.  12:4635-4645. 
21. Punt, J.A.,  R..T. Kubo, T. Saito, T.H. Finkel, S. Kathiresan, 
K.J. Blank,  and Y.  Hashimoto.1991. Surface expression  of a 
T cell receptor (TCR-[3) chain in the absence of TCP,.-{x, -B, 
-"/proteins.J. Exp. Med.  174:775-783. 
22. Kashl, H., P.  Borguyla,  B.  Scott,  K. Karjalainen, A.  Traun- 
ecker, J.  Kaufman, and H. yon Boehmer.  1991. Surface ex- 
pression of the [3 T cell receptor (TCP,) chain in the absence 
of other TCR or CD3 proteins on immature T cells. EMBO 
(Eur.  Mol.  Biol.  Organ.)J.  10:93-100. 
23. Groettrup, M., A.  Baron, G.  Griffiths,  P,.  Palacios, and H. 
Von Boehmer.  1992.  T  cell  receptor  (TCP,)  [3  chain ho- 
modimers on the surface of immature but not mature e~, y, 
chain deficient T cell hnes. EMBO (Eur.  Mol.  Biol.  Organ.)J. 
11:2735-2746. 
24. Borst, J.,  H. Jacobs,  and G. Brouns. 1996. Composition and 
function ofT-cell receptor and B-cell receptor complexes on 
precursor lymphocytes.  Cur.  Opin.  Immunol.  132:49-84. 
25. Shinkal,  Y.,  S. Koyasu,  K.  Nakayama,  K.M. Murphy, D.Y. 
Loh,  E.L.R.emherz, and F.W. Alt.  1993.  R.estorauon of T 
cell  development in P,.AG-2  deficient mice  by  funcnonal 
TCP, transgenes. Science (Wash. DC). 259:822-825. 
26. Jacobs, H., D. Vandeputte, L. Tolkamp, E. de Vries, J. Borst, 
and A. Berns.  1994. CD3 components at the surface ofpro-T 
cells can mediate pre-T cell development. Eur. J.  Immunol. 
24:934-939. 
27. Groettrup, M.,  K.  Ungewlss, O.  Azogul, R.  Palacios, M.J. 
Owen, A.C. Hayday,  and H. von Boehmer.  1993. A novel 
disulfide-linked heterodlmer on pre-T  cells consists  of the 
TCR [3 chain and a 33 kD glycoprotein. Cell. 75:283-294. 
28. Saint-Ruf, C.,  K.  Ungewlss, M.  Groettrup, L.  Bruno, HJ. 
Fehling, and H. von Boehmer. 1994. Analysis and expression 
of a  cloned pre-T cell  receptor  gene.  Science (Wash.  DC). 
266:1208-1212. 
29. Fehhng, H.J., A. Krotkova, C. Saint-RuE and H. von Boeh- 
mer. 1995. Crucial role of the pre-T-cell receptor oL gene in 
development of ~x[3 but not y8 T  cells. Nature  (Lond.).  375: 
795-798. 
30. Levelt, C.N., P. Mombaerts, A. Iglesias, S. Tonegawa, and K. 
Eichmann. 1993. Restoration of early thymocyte differentia- 
non in T  cell  receptor  [3-cham-deficmnt  mutant mice  by 
transmembrane signaling  through CD3e. Proc. Natl. Acad.  Sci. 
USA.  90:11401-11405. 
31. Shinkai, Y.,  and F.W.  Alt.  1994.  CD3e-medlated signals 
rescue  the  development  of  CD4+CD8 +  thymocytes  in 
RAG-2  "  mice in the absence  of TCR[3 chain expression. 
Int. Immun.  6:995-1001. 
32. Winoto, A., S. Mjolsness, and L. Hood. 1985. Genomic orga- 
nizauon of the genes encochng mouse T-cell receptor o~-chain. 
Nature (Lond.).  316:837-840. 
33. Lafaille, J.J.,  K.  Nagashlma,  M.  Katsuki,  and S.  Tonegawa. 
1994. High incidence of spontaneous autoxmmune encepha- 
lomyelms m immunodeficient anti-myelin  basic protein T cell 
receptor transgenic mice. Cell.  78:399-408. 
34. Hogan, B., F. Constantmi, and E. Lacy. 1986. Mampulating the 
1842  TCR[3 Chain Domains Controlling  Early Thymocyte Development mouse embryo. Cold Spnng Harbor Laboratory,  Cold Spring 
Harbor, NY. 
35. Laird,  P.W., A.  Zijdeveld, K.  Linders,  M.A.  1Ludnlckl, 1Z. 
Jaenisch,  and A.  Berns.  1991. Simplified  mammallan DNA 
xsolation procedure. Nucleic Acid Res.  19:4293. 
36.  Cuypers, H.T., G. Selten, W. Quint, M. Zijstra, ElK. Maan- 
dag,  W.  Boelens,  P.  van Wezenberg,  C.  Melief,  and  A. 
Berns.  1984.  Murane  leukemia virus-induced T-cell  lym- 
phomagenesis:  integration of provirusses  in a &stmct  chro- 
mosomal regaon. Cell. 37:141-150. 
37. Lai, E., IL. Barth,  and L.E. Hood.  1987. Genomlc orgamza- 
tion of the mouse T-cell receptor [3 gene family. Proc. Natl. 
Acad.  Sci. USA. 84:3846-3850. 
38. Chlen,  Y.,  N.R.J.  Gascoigne,  J.  Kavaler,  N.E.  Lee,  and 
M.M. Davis. 1984. Somatic recombination  in a routine T cell 
receptor gene. Nature (Lond.).  309:322-326. 
39. Maniatls, T., E.F. Fratsch., andJ. Sambrook. 1982. Molecular 
Cloning: A Laboratory  Manual. Cold Spring Harbor Labora- 
tory, Cold Spring Harbor, NY. 
40. Salto,  H.,  D.M.  Kranz,  Y.  Tagagakl,  A.C.  Hayday,  H.N. 
Elsen,  and S.  Tonegawa.  1984.  A third rearranged  and ex- 
pressed  gene in a clone of cytotoxic T  lymphocytes. Nature 
(Lond.).  312:36-40. 
41. Hedrick, S.M.,  E.A.  Nielsen, J.  Kavaler,  D.I. Cohen, M.M. 
Davis.  1994. Sequence relauonshlps between putative T-cell 
receptor polypepudes and immunoglobulins. Nature  (Lond.). 
308:153-158. 
42. Dodemont, H.J., P. Soriano, W.J. Quax., F. Ramaekers, J.A. 
Lenstra,  M.A. Groenen, G. Bemardi, and H. Bloemendahl. 
1982.  The  genes  coding for the  cytoskeletal  proteins actm 
and vimentinm in warmblooded vertebrates.  EMBO  (Eur. 
Mol. Biol.  Organ.)J.  1:167-171. 
43. Leo, O., M. Foo, D.H. Sachs, L.E. Samelson, and J.A. Blue- 
stone.  1987.  Identification of monoclonal antibody specific 
for a murlne T3 polypeptide. Proc. Natl, Acad.  Sci. USA.  84: 
1374-1378. 
44. Kubo, 1K.  T., W. Born, J.W. Kappler,  P.  Marrack,  and M. 
Pigeon.  1989.  Characterizauon of a  monoclonal antibody 
which  detects  all murme (x[3 T  cell  receptors.  J.  Immunol. 
142:2736-2742. 
45. payne, J., B.T. Huber, N.A. Cannon, IK. Schneider, M.W. 
Schilham,  H. Acha-Orbea, H. Robson MacDonald, and H. 
Hengartner. 1988. Two monoclonal rat antibodies with spec- 
ificity for the [3-chain variable region Vb6 of the murine T-cell 
receptor.  Proc. Natl. Acad.  Sci. USA. 85:7695-7698. 
46. Haskins, K., C. Hannurn,  J. White, N. Roehm, 1K. Kubo, J. 
Kappler,  and P. Marrack.  1984. The antigen-specific,  major- 
histocompatibility complex-restricted receptor on T  cells. J. 
Exp. Med.  160:452-471. 
47. Staerz, U.D., H.J. Rammensee, J.D. Benedetto, and M.J. Be- 
van.  1988.  Characterizauon of a  routine monoclonal anti- 
body specific for an allotyplc  determinant on T  cell antigen 
receptor.ft.  Immunol.  134:3994-4000. 
48. Ashwell, J.D., and Klausner,  R.D.  1990. Geneuc and muta- 
tional analysis of the T  cell antigen receptor.  Annu.  Rev.  Im- 
munol.  8:139-168. 
49. Klausner,  R.D., J.  Lippincott-Schwartz, and J.S.  Bonnofa- 
cino.  1990. The  T  cell  antigen receptor.  Insights  into or- 
ganelle biology. Annu. Rev.  Ceil. Biol. 6:403-431. 
50. Nflsson, T., P.A. Jackson,  and P.A. Peterson.  1989. Short cy- 
toplasmic  sequences  serve as retention signals for transmem- 
brane proteins in the endoplasmic reticulum.  Cell. 58:707-718. 
51. Jackson,  M.1K., T. Nilsson, and P.A. Peterson. 1990. Identifi- 
cauon of a consensus  motif for retention of transmembrane 
proteins  m  the  endoplasmic reticulum. EMBO  (Eur.  Mol. 
Biol.  Organ.)J.  9:3153-3162. 
52. Wilson, R.K., E.  Lai, P.  Concannon, R.K. Barth,  and L.E. 
Hood.  1988. Structure,  organization and polymorphism of 
munne and human T-cell receptor e¢ and [3 chain gene fami- 
lies. Immunol.  Rev.  101:149-172. 
53. Yancopoulos, G.D.,  S.V. Desiderio,  M.  Paskind, J.F.  Kear- 
ney, D. Baltimore, and F.W. Alt.  1984. Preferential  utiliza- 
tion of the most J(H)  proxamal V(H) gene segments m pre-B 
cell hnes. Nature  (Lond.).  311:727-733. 
54. Perlmutter, R.M,, J.F. Kearney, S.P. Chang, and L.E. Hood. 
1985. Developmentally controlled expression ofimmunoglo- 
bulin VH genes. Science (Wash. DC). 227:1597-1601. 
55. Yancopoulos, G.D., B.A. Malynn, and F.W. Alt.  1988. De- 
velopmentally  regulated and strata-specific  expression of mu- 
rine VH gene families.J.  Exp. Med.  168:417-435. 
56. Freltas, A.A., L. Andrade, M.P. Lembezat,  and A. Coutmho. 
1990. Expression  of VH gene repertoires:  Differentiating B 
cells of adult bone marrow mimic fetal development. Int.  Im- 
munol.  2:15-21. 
1843  Jacobs et al. 